Monday, 20 July 2026
Bundibugyo virus treatment trial, Child health impact in Ukraine, Pembrolizumab study correction
- 01
First Bundibugyo virus treatment trial begins
The PARTNERS trial has commenced to evaluate treatments for Bundibugyo virus infection. This trial aims to address the challenges of treating this emerging infectious disease. The initiative represents a significant advancement in research focused on infectious diseases, which is crucial for public health.
via The Lancet
- 02
Impact of Conflict on Child Health in Ukraine
The ongoing conflict in Ukraine, now in its fourth year, is expected to have lasting effects on the country's children. Despite efforts to maintain health services, the situation remains critical for child health and wellbeing. This report underscores the significant challenges faced by children in conflict zones, drawing attention to the broader implications for health systems.
via The Lancet
- 03
Correction Issued for Pembrolizumab Ovarian Cancer Study
A correction has been made to a major study on pembrolizumab in platinum-resistant recurrent ovarian cancer, published in The Lancet. The amendment clarifies the exclusion criteria for participants, specifically regarding disease progression after platinum treatment. This change is significant as it may influence treatment decisions based on the study's findings. The correction was updated in the online version of the article on July 16, 2026.
via The Lancet
- 04
Corrections Made to Audit on Fabricated Citations in Biomedical Papers
An audit examining fabricated citations across 2.5 million biomedical papers has prompted corrections in The Lancet. Nir Roguin's affiliations were updated to reflect only those of Tel Aviv Sourasky Medical Center and Ben-Gurion University. The corrections were made to the online version of the correspondence as of July 16, 2026. This audit raises concerns about research integrity, which is crucial for clinicians relying on evidence-based practices.
via The Lancet
- 05
US Plan Targets Psychiatric Overprescribing Amid Controversy
US Secretary of Health and Human Services Robert F Kennedy Jr has made controversial claims about antidepressants, alleging they are more addictive than heroin and linked to school shootings. In response, the announcement of the Make America Healthy Again Action Plan aims to address psychiatric overprescribing, focusing on reducing long-term medication use when it does not improve patient outcomes. Health officials clarified that the plan does not intend to ban specific antidepressants. This initiative has raised concerns within health circles regarding its implications for mental health treatment.
via The Lancet
- 06
Critique of Nuclear Power's Safety Narrative
A correspondence in The Lancet critiques the portrayal of nuclear power as a safe and clean energy source. The author argues that the focus on reactor operations and minimisation of hazards overlooks other significant dangers associated with nuclear energy. This commentary challenges the narrative that nuclear power can effectively address rising electricity demand and climate change.
via The Lancet
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.